Navigation Links
Quality-of-life issues need to be addressed for CML patients, Moffitt researchers say
Date:6/10/2013

Researchers at Moffitt Cancer Center have determined that chronic myeloid leukemia patients who are treated with a class of oral chemotherapy drugs known as a tyrosine kinase inhibitors have significant side effects and quality-of-life issues that need to be addressed. Some of these issues include depression, fatigue, nausea and change of appearance. The researchers say it is important to improve the patients' quality of life because most will take tyrosine kinase inhibitors for the rest of their lives.

Their study appeared in the April issue of Supportive Care in Cancer.

"Although much less toxic than the treatments they replaced, tyrosine kinase inhibitors, such as imatinib, nilotinib or dasatinib, do cause symptoms that adversely affect a patient's quality of life," said study senior author Paul B. Jacobsen, Ph.D., associate center director and senior member of the Health Outcomes and Behavior Program at Moffitt.

Tyrosine kinase inhibitors are standard treatment for chronic myeloid leukemia. Using several quality-of-life measurement tools, researchers compared chronic myeloid leukemia patients taking tyrosine kinase inhibitors for a minimum of six months to a group of participants of the same age and gender who did not have cancer. The most common side effects among study participants were fatigue, pain and difficulty concentrating.

Another side effect that researchers say proved to be significant was appearance. Twenty-nine percent of patients reported distress over not looking like themselves.

"To our knowledge other studies have not addressed patients' concerns about their appearance," Jacobsen said. "We found that skin changes, such as swelling, are distressing for patients taking tyrosine kinase inhibitors."

The researchers concluded that their findings "point to the need to develop interventions that can address quality of life for patients with chronic myeloid leukemia who are taking tyrosine kinase inhibitors."


'/>"/>

Contact: Kim Polacek
kim.polacek@moffitt.org
813-745-7408
H. Lee Moffitt Cancer Center & Research Institute
Source:Eurekalert

Related medicine news :

1. UCSF chancellor issues call-to-arms to patient advocates
2. Radiologists rank themselves as less than competent on health policy issues
3. Genetic abnormalities in benign or malignant tissues predict relapse of prostate cancer
4. FDA Issues Multiple Sclerosis Drug Alert
5. Quality of care, other issues may cause worse results in black prostate cancer surgery patients
6. U.S. Task Force Issues Blood Pressure Guidelines
7. Internists in Washington to discuss patient and professional issues in meetings on Capitol Hill
8. Cheaper drug could lead to serious eye issues
9. Insulite Labs announces the launch of the PCOS Inspiration Hour, a one hour virtual gathering place for women with PCOS and other women’s health issues to come together.
10. LawyersandSettlements.com Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation
11. What Men Should Know About Veins: Varicose Veins and Venous Disease are Real Medical Issues
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... , ... Tuesday, May 24, Women's Excellence in Wellness, powered by Movestrong will ... Oils, taught by Patti Dolan, RYT, a Young Living Gold Member. The class ... - 7:15pm followed by a small intro to the Oils that can benefit the ...
(Date:5/24/2016)... , ... May 24, 2016 , ... In light of ... aware of the potential of contaminated well water throughout the Houston area. , Heavy ... with well water that’s exposed to contaminants. Residents may not even be aware of ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... "ProText Layouts ... said Christina Austin - CEO of Pixel Film Studios. , ProText Layouts Vol. 3 ... Final Cut Pro X . With ProText Layouts, video editors can create an ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... After graduating ... He spent the next decade in hospitals, on medication, living on Social Security disability ... at the Illness and How I Beat It!” (published by Balboa Press), Alexander shares ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... its highly anticipated, web-based software module. The cutting-edge feature provides end users ... Integration with Izenda’s self-service business intelligence solution and its analytics engine. ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... 23, 2016 Experts from various ... Medicine and the role of technology in innovative ... The First International Conference of VPS-Penn Medicine opened in ... and presence of Sheikh Nahyan bin Mubarak Al Nahyan, Minister ... Medicine, which helps provide personalized medicine and tailor-made healthcare in ...
(Date:5/23/2016)... -- The global  reprocessed medical devices market ... according to a new study by Grand View Research, ... the lack of centralized support for waste disposal in ... for reprocessed medical devices market. Additionally, the long-term cost-efficiency ... the original device is the high impact rendering driver ...
(Date:5/22/2016)... 2016 DS Biopharma (DS) ... anti-inflammatory compound DS102 in chronic obstructive pulmonary disease ... (NASH) patients. Recent DS preclinical data ... tissue and has bronchodilatory, anti-inflammatory and anti-fibrotic properties ... Company will publish further detail on these findings ...
Breaking Medicine Technology: